Accessible Pharmaceutical Labelling

In compliance with European Directive 2004/27/EC - Article 56(a), all medicine sold in the European Union must have the product name in braille on the packaging. Likewise, the patient information leaflet (found inside the medicine package) must be made available in alternative formats.

Update (March 2010)

The European Blind Union has worked across its member states and with the pharmaceutical and packaging industries, alongside its involvement with the CEN standard development for braille on packaging and leaflets, and has developed a range of information to help the industry to comply with EU Directive 2004/27/EC.

Other useful information